申请人:Merck Frosst Canada, Inc.
公开号:US04666907A1
公开(公告)日:1987-05-19
Phenothiazine derivatives and analogs thereof having the Formula I are useful as inhibitors of the biosynthesis of mammalian leukotrienes. As such, these compounds are useful therapeutic agents for treating allergic conditions, asthma, cardiovascular disorders and inflammation, and are useful as cytoprotective agents. ##STR1##
苯噻嗪衍生物及其类似物具有式I的公式,可用作哺乳动物白三烯生物合成的抑制剂。因此,这些化合物是用于治疗过敏症、哮喘、心血管疾病和炎症的有用治疗剂,并且可用作细胞保护剂。